课题基金 / 基金详情

PROJECT 3 : QUANTITATIVE BIOMARKERS OF DNA AND PROTEIN OXIDATION

PROJECT 3 : QUANTITATIVE BIOMARKERS OF DNA AND PROTEIN OXIDATION
项目 3:DNA 和蛋白质氧化的定量生物标志物
批准号:
7724078
负责人:
Paul Thomas Henderson
金额:
$29.81万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2009-08-31

项目摘要

项目成果

Paul Thomas Henderson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Project 3 is developing methods to quantify oxidative modifications in DNA, proteins, and metabolites. We will focus on introducing 14C isotope labels into biological molecules in order to characterize pathways and biomarkers of relevance to human disease. This labeling is done by either dosing cells or animals with a labeled building block such as an amino acid for incorporation into proteins or a nucleoside for synthesis of DNA. Two main objectives of Project 3 are: (1) characterization of nucleotide pool oxidation products that are incorporated into DNA and RNA and (2) chlorination of proteins by HOCl produced by myeloperoxidase during the activation of white blood cells. Completion of these objectives will enable progress towards the general goal of quantifying the metabolic flux of molecules produced as a result of oxidative stress which may be related to cancer, diabetes, arteriosclerosis and numerous aging-related diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ninja Theranostics for overcoming the drug delivery barriers to pediatric brain tumor
  • 批准号:
    9681305
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2018
  • 负责人:
    Paul Thomas Henderson
  • 依托单位:
Phase 0 carboplatin microdosing diagnostics trial
DEVELOP ASSAY TO QUANT PLAT-DNA ADDUCTS & PREDICT RESPONSE TO CHEMOTHERA
OXIDIZED DNA BASES AS BIOMARKERS OF TUMOR PROGRESSION
海外基金